Free Trial
LON:CNSL

Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis

GBX 2.80 -0.03 (-0.88%)
As of 03:08 AM Eastern

About Cambridge Nutritional Sciences Stock (LON:CNSL)

Key Stats

Today's Range
2.80
3.05
50-Day Range
2.80
3.81
52-Week Range
2.70
4.48
Volume
2,891 shs
Average Volume
416,894 shs
Market Capitalization
£6.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

Remove Ads
Receive CNSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter.

CNSL Stock News Headlines

See More Headlines

CNSL Stock Analysis - Frequently Asked Questions

Cambridge Nutritional Sciences' stock was trading at GBX 2.80 at the start of the year. Since then, CNSL stock has increased by 0.1% and is now trading at GBX 2.80.
View the best growth stocks for 2025 here
.

Cambridge Nutritional Sciences plc (LON:CNSL) posted its earnings results on Thursday, November, 21st. The company reported ($0.10) earnings per share (EPS) for the quarter. Cambridge Nutritional Sciences had a negative net margin of 3.36% and a negative trailing twelve-month return on equity of 3.34%.

Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Last Earnings
11/21/2024
Today
3/31/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Communication
Current Symbol
LON:CNSL
CIK
N/A
Fax
N/A
Employees
3,200
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
75.95
P/E Growth
N/A
Net Income
£-3,030,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.77 million
Price / Cash Flow
N/A
Book Value
GBX 4 per share
Price / Book
0.70

Miscellaneous

Free Float
N/A
Market Cap
£6.66 million
Optionable
N/A
Beta
3.89
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:CNSL) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners